| MiCBT Research – Selected Studies

Effectiveness of mindfulness-integrated cognitive behavior therapy on anxiety, depression and hope in multiple sclerosis patients: a randomized clinical trial

Sahar Pouyanfard, Mohsen Mohammadpour, Ali A. ParviziFard, Kheirollah Sadeghi 1

1 Department of Clinical Psychology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran


Introduction: Multiple sclerosis (MS) is a chronic medical condition that attracts particular attention because of the high risks associated with it. MS patients suffer from medical problems, depression, anxiety, and reduced hopefulness. These issues can increase the severity of the disease and treatment resistance and reduce patients’ individual and social efficacy. Mindfulness-integrated cognitive behavior therapy (MICBT) is a new approach that is being applied in chronic diseases and can be used in combination with existing treatments. Therefore, the present study investigated the efficacy of MICBT in terms of anxiety, depression, and hope in MS patients.

Methods: A sample of 20 patients with MS was randomly selected at Shafa Hospital in Kerman City, Iran. Patients were then assigned to one of two groups of 10 people using a random number table. The experimental group received MICBT. The control group also received the same therapy after study completion. The assessment tools used in this study included the Beck Depression Inventory-Second Edition (BDI-II), Beck Anxiety Inventory (BAI), and Miller Hope Scale (MHS). Measurements were conducted at three stages: pre-test, post-test, and follow-up. For data analysis, means and standard deviations were calculated and one-way analysis of covariance was conducted using SPSS 24.

Results: Compared with controls, MICBT was effective for reducing depression (P < 0.001, F = 72.55), anxiety (P < 0.001, F = 100.75). Additionally, MICBT was effective in improving hope (P < 0.001, F = 45.36). Changes were maintained in the follow-up phase.

Conclusion: The MICBT affects depression, anxiety and hope of MS patients. Therefore, mental health professionals can benefit from the results obtained in the present study to reduce depression and anxiety and increase hope in this group of patients.

Read the full article here:
Trends Psychiatry Psychother. 42 (1) • Jan-Mar 2020

Effectiveness of Mindfulness-integrated Cognitive Behavioural Therapy (MiCBT) on body image and emotional regulation in mastectomy patients: a randomized clinical trial

July 10, 2023

Efficacy of mindfulness and goal setting interventions for increasing resilience and reducing smoking in lower socioeconomic groups: randomised controlled trial protocol

February 6, 2023

Confirmation and Validation of the Equanimity Scale-16 (ES-16)

December 4, 2022

La MiCBT une nouvelle approche des interventions basées sur la pleine conscience: différences et similarités de 3 thérapies

November 9, 2022

(ES- ویژگیهای روانسنجی نسخه فارسی مقیاس تعادل ذهنی ( 16<br>Psychometric Properties of the Persian Version of Equanimity Scale 16 (ES-16)

November 7, 2022

The Equanimity Scale-16

October 31, 2022

Group Mindfulness-Integrated Cognitive Behavior Therapy (MiCBT) Reduces Depression and Anxiety and Improves Flourishing in a Transdiagnostic Primary Care Sample Compared to Treatment-as-Usual: A Randomized Controlled Trial

June 10, 2022

Validation and Factor Structure of the Mindfulness‑Based Self Efficacy Scale‑Revised

February 7, 2022

Managing type 2 diabetes and depression with Mindfulness-integrated Cognitive Behavior Therapy (MiCBT)

February 2, 2022

The Effectiveness of Mindfulness-integrated Cognitive Behavioral Therapy (MiCBT), Meta-Cognitive Therapy (MCT), Acceptance and Commitment Therapy (ACT), and Cognitive Behavioral Therapy (CBT) on Obsessive-compulsive disorder (OCD)

October 15, 2021
Scroll to Top